Indications |
Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: Apply as a 0.1% cream/lotion/ointment onto affected area. |
Contraindications |
Primary infectious (viral, fungal, bacterial) ulcers, hypersensitivity, acne vulgaris. |
Warnings / Precautions |
Neonates, childn, elderly, hepatic failure. Not to be applied over large areas under occlusive dressings. Caution when applied to areas of broken skin. Pregnancy, lactation. |
Adverse Reactions |
Prolonged application causes epidermal thinning, contact dermatitis, perioral dermatitis, papular disorder, mild depigmentation; telangiectasia, striae (especially face and flexures). Application on eyelids and surrounding skin can raise intraocular pressure, cataracts, glaucoma, corneal ulcers and raised intracranial pressure. Systemic absorption with adrenal suppression may be seen when applied to large areas, when skin is broken or under occlusive dressing. Potentially Fatal: HPA suppression; suppression of immune system. |
Mechanism of Actions |
Halcinonide exerts anti-inflammatory, antipruritic and vasoconstrictor actions. |
Storage Conditions |
Topical/Cutaneous: Store below 40°C. |
ATC Classification |
D07AD02 - halcinonide ; Belongs to the class of very potent (group IV) corticosteroids. Used in the treatment of dermatological diseases. |
Storage |
Topical/Cutaneous: Store below 40°C. |
Available As |
|
Halcinonide
Post Review about Halcinonide Click here to cancel reply.
Halcinonide Containing Brands
Halcinonide is used in following diseases
Drug - Drug Interactions of Halcinonide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.